Diatech is an Italian company which operates in the molecular oncological diagnostics segment. It offers products and support services to laboratories in this field. The company is the leader in the Italian market with more than 60% market share and it has started an internationalization process among other European countries.
Alto Partners SGR is an independent company which promotes and manages Private Equity funds that invest in Small and Medium Italian Enterprises.
Cross Border supported Diatech’s ownership in the research of a minority partner in order to support the company’s growth. Alto Partners has been selected after a process which has included other counterparts and a careful focus on the strategic and qualitative fit. The transaction took the structure of a sale of shares by the historical shareholders, moreover a management incentive plan was designed (through stock options).